Why is Auro Labs. falling/rising?

As of 24-Jul, Auro Laboratories Ltd is currently priced at 278.70, reflecting a slight increase of 0.55, or 0.2%. The stock has shown a trend reversal by gaining after two consecutive days of decline. Despite a recent drop in delivery volume by 48.55% compared to the 5-day average, the stock remains above its 20, 50, 100, and 200-day moving averages, indicating a generally positive trend. Over the past year, Auro Laboratories has delivered a remarkable return of 55.87%, significantly outperforming the BSE500 index, and has demonstrated strong management efficiency with a high return on capital employed (ROCE) of 24.16% and a low debt to EBITDA ratio of 0.70 times.
In the broader market context, Auro Laboratories' performance over the past week shows a decline of 3.46%, while the Sensex has only decreased by 0.09%, indicating that the stock has underperformed relative to the benchmark in the short term. However, the stock's long-term performance remains robust, with a 215.99% increase over three years, compared to the Sensex's 46.57% rise during the same period. This suggests that while the stock may be experiencing short-term volatility, its overall trajectory remains positive, supported by strong fundamentals and management efficiency.